Table 4.
Relative amiloride-sensitive currents in WT hENaC and hENaC M1 mutants
ConstructIK/INa (−100 mV)ILi/INa (−100 mV)ICs/INa (−100 mV)n
WT hENaC −0.04 ± 0.04 1.2 ± 0.2 −0.04 ± 0.04 
α(W-1′A)βγ -0.02 ± 0.02 1.5 ± 0.4 −0.04 ± 0.06 
α(W0′F)βγ −0.02 ± 0.00 2.2 ± 0.5 −0.03 ± 0.00 
α(W0′F)β(W0′F)γ 0.2 ± 0.3a 3.5 ± 1.3b 0.03 ± 0.06 
α(W0′F)β(W0′F)γ(W0′F) n.d. n.d. n.d.  
α(W4′A)βγ 0.00 ± 0.02 1.7 ± 0.5 0.0 ± 0.1 
α(W4′A)β(T4′A)γ 0.00 ± 0.06 2.0 ± 0.9 −0.1 ± 0.1c 3–4 
α(W4′A)β(T4′A)γ(T4′A) 0.00 ± 0.02 1.5 ± 0.3 −0.02 ± 0.01 
α(F8′A)βγ −0.1 ± 0.1c 0.9 ± 0.2 −0.1 ± 0.1a 5–6 
α(Y12′A)βγ −0.03 ± 0.05 1.4 ± 0.5 −0.04 ± 0.1 4–6 
α(W13′A)βγ −0.00 ± 0.01 1.0 ± 0.5 −0.01 ± 0.01 
α(W13′A)β(W13′A)γ −0.00 ± 0.01 1.0 ± 0.7 −0.00 ± 0.01 4–7 
α(W13′A)β(W13′A)γ(W13′A) 0.02 ± 0.02 1.2 ± 0.2 −0.01 ± 0.01 6–8 
α(F15′A)βγ 0.01 ± 0.02 2.0 ± 0.3 −0.01 ± 0.00 
α(F15′A)β(W15′A)γ 0.01 ± 0.01 2.0 ± 0.5 0.01 ± 0.02 4–5 
α(F15′A)β(W15′A)γ(C13′A) 0.00 ± 0.01 2.2 ± 0.8 −0.03 ± 0.01 
α(F19′A)βγ 0.04 ± 0.08a 2.0 ± 1.0c −0.01 ± 0.03 9–12 
α(Y22′A)βγ 0.01 ± 0.01 2.6 ± 0.3d 0.09 ± 0.1d 3–5 
α(Y23′A)βγ 0.05 ± 0.03c 1.3 ± 0.2 0.03 ± 0.05 
αβ(F1′A)γ 0.0 ± 0.0 1.3 ± 0.2 −0.03 ± 0.04 3–4 
αβ(F7′A)γ 0.0 ± 0.01 1.2 ± 0.4 −0.00 ± 0.00 3–5 
αβ(F18′A)γ 0.02 ± 0.01 1.4 ± 0.4 0.00 ± 0.02 3–5 
αβ(F22′A)γ 0.01 ± 0.01 2.1 ± 0.2c 0.01 ± 0.03 7–8 
αβγ(F3′A) −0.02 ± 0.03 1.7 ± 0.3 −0.00 ± 0.01 3–4 
αβγ(F20′A) 0.01 ± 0.00 1.7 ± 0.7 −0.00 ± 0.01 4–5 
αβγ(F24′A) −0.0 ± 0.0 1.8 ± 0.47 −0.01 ± 0.02 7–8 
αβγ(Y25′A) 0.04 ± 0.05 1.4 ± 0.20 −0.02 ± 0.01 3–5 
ConstructIK/INa (−100 mV)ILi/INa (−100 mV)ICs/INa (−100 mV)n
WT hENaC −0.04 ± 0.04 1.2 ± 0.2 −0.04 ± 0.04 
α(W-1′A)βγ -0.02 ± 0.02 1.5 ± 0.4 −0.04 ± 0.06 
α(W0′F)βγ −0.02 ± 0.00 2.2 ± 0.5 −0.03 ± 0.00 
α(W0′F)β(W0′F)γ 0.2 ± 0.3a 3.5 ± 1.3b 0.03 ± 0.06 
α(W0′F)β(W0′F)γ(W0′F) n.d. n.d. n.d.  
α(W4′A)βγ 0.00 ± 0.02 1.7 ± 0.5 0.0 ± 0.1 
α(W4′A)β(T4′A)γ 0.00 ± 0.06 2.0 ± 0.9 −0.1 ± 0.1c 3–4 
α(W4′A)β(T4′A)γ(T4′A) 0.00 ± 0.02 1.5 ± 0.3 −0.02 ± 0.01 
α(F8′A)βγ −0.1 ± 0.1c 0.9 ± 0.2 −0.1 ± 0.1a 5–6 
α(Y12′A)βγ −0.03 ± 0.05 1.4 ± 0.5 −0.04 ± 0.1 4–6 
α(W13′A)βγ −0.00 ± 0.01 1.0 ± 0.5 −0.01 ± 0.01 
α(W13′A)β(W13′A)γ −0.00 ± 0.01 1.0 ± 0.7 −0.00 ± 0.01 4–7 
α(W13′A)β(W13′A)γ(W13′A) 0.02 ± 0.02 1.2 ± 0.2 −0.01 ± 0.01 6–8 
α(F15′A)βγ 0.01 ± 0.02 2.0 ± 0.3 −0.01 ± 0.00 
α(F15′A)β(W15′A)γ 0.01 ± 0.01 2.0 ± 0.5 0.01 ± 0.02 4–5 
α(F15′A)β(W15′A)γ(C13′A) 0.00 ± 0.01 2.2 ± 0.8 −0.03 ± 0.01 
α(F19′A)βγ 0.04 ± 0.08a 2.0 ± 1.0c −0.01 ± 0.03 9–12 
α(Y22′A)βγ 0.01 ± 0.01 2.6 ± 0.3d 0.09 ± 0.1d 3–5 
α(Y23′A)βγ 0.05 ± 0.03c 1.3 ± 0.2 0.03 ± 0.05 
αβ(F1′A)γ 0.0 ± 0.0 1.3 ± 0.2 −0.03 ± 0.04 3–4 
αβ(F7′A)γ 0.0 ± 0.01 1.2 ± 0.4 −0.00 ± 0.00 3–5 
αβ(F18′A)γ 0.02 ± 0.01 1.4 ± 0.4 0.00 ± 0.02 3–5 
αβ(F22′A)γ 0.01 ± 0.01 2.1 ± 0.2c 0.01 ± 0.03 7–8 
αβγ(F3′A) −0.02 ± 0.03 1.7 ± 0.3 −0.00 ± 0.01 3–4 
αβγ(F20′A) 0.01 ± 0.00 1.7 ± 0.7 −0.00 ± 0.01 4–5 
αβγ(F24′A) −0.0 ± 0.0 1.8 ± 0.47 −0.01 ± 0.02 7–8 
αβγ(Y25′A) 0.04 ± 0.05 1.4 ± 0.20 −0.02 ± 0.01 3–5 

Relative amiloride-sensitive currents determined for WT ENaC and hENaC mutants containing the designated amino acid substitutions at positions with aromatic side chain. Data are shown as mean ± SD; n.d., not determined. n refers to the number of individual oocytes. Values for mutants were compared with WT hENaC using one-way ANOVA with Dunnett’s multiple comparisons test.

a

P < 0.01.

b

P < 0.0001.

c

P < 0.05.

d

P < 0.001.

or Create an Account

Close Modal
Close Modal